Media, Video 22 Jul 2022 VIDEO | Proactive Investors – July 2022 Orthocell’s Paul Anderson spoke with Alisha Newell at Proactive Investors to discuss the Company’s strong position following the recently executed… Orthocell
Media 22 Jul 2022 Dr Boreham’s Crucible | July 2022 Orthocell was featured in the widely read column, Dr Boreham’s Crucible, written by respected small cap analyst and business journalist,… Orthocell
Media, Video 08 Jul 2022 VIDEO | ShareCafe ‘Hidden Gems’ Webinar – July 2022 Orthocell CEO and Managing Director, Paul Anderson, recently participated in the ShareCafe Small Cap ‘Hidden Gems’ Webinar. Orthocell
Company News 27 Jun 2022 Striate+™ global exclusive license and manufacturing agreement with BioHorizons Orthocell (ASX:OCC) has signed a global exclusive license and manufacturing agreement for its FDA-cleared dental product, Striate+™, with BioHorizons Implant… Orthocell
Media, Video 12 May 2022 Remplir™ Channel 7 News feature Clinical trial participant Damian Hall was featured in a national news story by Channel 7 News Reporter, Alison Fan, to… Orthocell
Company News 29 Apr 2022 Quarterly Report | Period To 31 March 2022 Orthocell has today published its Quarterly Report for the period ended 31 March 2022. Standout achievements for this Quarter include:… Orthocell
Media, Video 22 Mar 2022 VIDEO | Proactive Investors – March 2022 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Company News 21 Mar 2022 TGA Approval for Remplir™ Orthocell’s Remplir™ device has gained Australian regulatory (Therapeutics Goods Administration) approval. Orthocell
Company News 28 Feb 2022 Striate+™ Market Update Orthocell’s Striate+™ dental membrane, which facilitates high quality and efficient bone and tissue repair, is gaining commercial momentum. Orthocell
Company News 11 Feb 2022 Meet Orthocell’s Quality Director, Monique Cannon On International Day of Women In Science, we’re proud to shine a spotlight on Orthocell’s Quality Director, Monique Cannon. Orthocell